Decreased levels of circulating adiponectin in mild cognitive impairment and alzheimer's disease

NeuroMolecular Medicine

Volumn 15, Issue 1, 2013, Pages 115-121

  Teixeira, Antonio L ^a   Diniz, Breno S ^b   Campos, Alline C ^a   Miranda, Aline S ^a   Rocha, Natalia P ^a   Talib, Leda L ^b   Gattaz, Wagner F ^b   Forlenza, Orestes V ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiponectin; Alzheimer's disease; Cognition; Inflammation; Mild cognitive impairment

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN E; GENOMIC DNA;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COGNITION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EDUCATIONAL STATUS; ELDERLY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADIPONECTIN; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; BODY MASS INDEX; BRAZIL; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DYSLIPIDEMIAS; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS;

EID: 84874675898     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-012-8201-2     Document Type: Article

References (39)

1. Arosio, B.; Trabattoni, D.; Galimberti, L.; Bucciarelli, P.; Fasano, F.; Calabresi, C.; et al. (2004). Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiology of Aging, 25(8), 1009-1015. doi: 10.1016/j.neurobiolaging.2003.10.009. (Pubitemid 38798062)
2. Bigalke, B.; Schreitmuller, B.; Sopova, K.; Paul, A.; Stransky, E.; Gawaz, M.; et al. (2011). Adipocytokines and CD34 progenitor cells in Alzheimer's disease. PLoS ONE, 6(5), e20286. doi: 10.1371/journal.pone.0020286.
3. Calvani, M.; Scarfone, A.; Granato, L.; Mora, E. V.; Nanni, G.; Castagneto, M.; et al. (2004). Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes, 53(4), 939-947. (Pubitemid 38436605)
4. Diniz, B. S.; Nunes, P. V.; Yassuda, M. S.; Pereira, F. S.; Flaks, M. K.; Viola, L. F.; et al. (2008). Mild cognitive impairment: Cognitive screening or neuropsychological assessment? Revista Brasileira de Psiquiatria, 30(4), 316-321.
5. Diniz, B. S.; Teixeira, A. L.; Campos, A. C.; Miranda, A. S.; Rocha, N. P.; Talib, L. L.; et al. (2012). Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research, 46(8), 1081-1085. doi: 10.1016/j.jpsychires.2012.04.028.
6. Diniz, B. S.; Teixeira, A. L.; Ojopi, E. B.; Talib, L. L.; Mendonca, V. A.; Gattaz, W. F.; et al. (2010). Higher serum sTNFR1 level predicts conversion from mild Cognitive impairment to Alzheimer's disease. Journal of Alzheimer's Disease, 22(4), 1305-1311. doi: 10.3233/JAD-2010-100921.
7. Dzielinska, Z.; Januszewicz, A.; Wiecek, A.; Demkow, M.; Makowiecka-Ciesla, M.; Prejbisz, A.; et al. (2003). Decreased plasma concentration of a novel anti-inflammatory protein - adiponectin - in hypertensive men with coronary artery disease. Thrombosis Research, 110(5-6), 365-369. (Pubitemid 37329841)
8. Fasshauer, M.; Kralisch, S.; Klier, M.; Lossner, U.; Bluher, M.; Klein, J.; et al. (2003). Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications, 301(4), 1045-1050. (Pubitemid 36279218)
9. Folstein, M. F.; Folstein, S. E.; & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.
10. Forlenza, O. V.; Diniz, B. S.; & Gattaz, W. F. (2010a). Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Medicine, 8, 89. doi: 10.1186/1741-7015-8-89.
11. Forlenza, O. V.; Diniz, B. S.; Talib, L. L.; Mendonca, V. A.; Ojopi, E. B.; Gattaz, W. F.; et al. (2009). Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 28(6), 507-512. doi: 10.1159/000255051.
12. Forlenza, O. V.; Diniz, B. S.; Talib, L. L.; Radanovic, M.; Yassuda, M. S.; Ojopi, E. B.; et al. (2010b). Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria, 32(3), 216-222.
13. Giordano, V.; Peluso, G.; Iannuccelli, M.; Benatti, P.; Nicolai, R.; & Calvani, M. (2007). Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia. Neurochemistry Research, 32(4-5), 555-567. doi: 10.1007/s11064-006-9125-8. (Pubitemid 46481288)
14. Gu, Y.; Luchsinger, J. A.; Stern, Y.; & Scarmeas, N. (2010). Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. Journal of Alzheimer's Disease, 22(2), 483-492. doi: 10.3233/JAD-2010-100897.
15. Hara, K.; Horikoshi, M.; Yamauchi, T.; Yago, H.; Miyazaki, O.; Ebinuma, H.; et al. (2006). Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 29(6), 1357-1362. doi: 10.2337/dc05-1801. (Pubitemid 44125935)
16. Hayes, A.; Thaker, U.; Iwatsubo, T.; Pickering-Brown, S. M.; & Mann, D. M. (2002). Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease. Neuroscience Letters, 331(3), 171-174. (Pubitemid 35279801)
17. Hivert, M. F.; Sullivan, L. M.; Fox, C. S.; Nathan, D. M.; D'Agostino, R. B.; Sr, Wilson, P. W.; et al. (2008). Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 93(8), 3165-3172. doi: 10.1210/jc.2008-0425.
18. Holmes, C.; Cunningham, C.; Zotova, E.; Woolford, J.; Dean, C.; Kerr, S.; et al. (2009). Systemic inflammation and disease progression in Alzheimer disease. Neurology, 73(10), 768-774. doi: 10.1212/WNL.0b013e3181b6bb95.
19. Kobayashi, H.; Ouchi, N.; Kihara, S.; Walsh, K.; Kumada, M.; Abe, Y.; et al. (2004). Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research, 94(4), e27-e31. doi: 10.1161/01.RES.0000119921.86460.37.
20. Livak, K. J. (1999). Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genetic Analysis, 14(5-6), 143-149. (Pubitemid 29095371)
21. Maeda, N.; Shimomura, I.; Kishida, K.; Nishizawa, H.; Matsuda, M.; Nagaretani, H.; et al. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine, 8(7), 731-737. doi: 10.1038/nm724. (Pubitemid 34778727)
22. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7), 939-944. (Pubitemid 14076461)
23. Mrak, R. E. (2009). Neuropathology and the neuroinflammation idea. Journal of Alzheimer's Disease, 18(3), 473-481. doi: 10.3233/JAD-2009-1158.
24. Ouchi, N.; Kihara, S.; Funahashi, T.; Matsuzawa, Y.; & Walsh, K. (2003). Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology, 14(6), 561-566. doi: 10.1097/01.mol.0000103609.38789.96. (Pubitemid 41623184)
25. Pajvani, U. B.; Hawkins, M.; Combs, T. P.; Rajala, M. W.; Doebber, T.; Berger, J. P.; et al. (2004). Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry, 279(13), 12152-12162. doi: 10.1074/jbc.M311113200. (Pubitemid 38445780)
26. Petersen, R. C.; Doody, R.; Kurz, A.; Mohs, R. C.; Morris, J. C.; Rabins, P. V.; et al. (2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985-1992. (Pubitemid 33143977)
27. Poehlman, E. T.; & Dvorak, R. V. (1998). Energy expenditure in Alzheimer's disease. Journal of Nutrition Health and Aging, 2(2), 115-118. (Pubitemid 128695288)
28. Ray, S.; Britschgi, M.; Herbert, C.; Takeda-Uchimura, Y.; Boxer, A.; Blennow, K.; et al. (2007). Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nature Medicine, 13, 1359-1362. doi: 10.1038/nm1653. (Pubitemid 350073592)
29. Roberts, R. O.; Geda, Y. E.; Knopman, D. S.; Boeve, B. F.; Christianson, T. J.; Pankratz, V. S.; et al. (2009). Association of C-reactive protein with mild cognitive impairment. Alzheimers & Dementia, 5(5), 398-405. doi: 10.1016/j.jalz.2009.01.025.
30. Roth, M.; Tym, E.; Mountjoy, C. Q.; Huppert, F. A.; Hendrie, H.; Verma, S.; et al. (1986). CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149, 698-709. (Pubitemid 17205276)
31. Sonnen, J. A.; Santa Cruz, K.; Hemmy, L. S.; Woltjer, R.; Leverenz, J. B.; Montine, K. S.; et al. (2011). Ecology of the aging human brain. Archives of Neurology, 68(8), 1049-1056. doi: 10.1001/archneurol.2011.157.
32. Spranger, J.; Verma, S.; Gohring, I.; Bobbert, T.; Seifert, J.; Sindler, A. L.; et al. (2006). Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes, 55(1), 141-147. (Pubitemid 43343309)
33. Tarkowski, E.; Andreasen, N.; Tarkowski, A.; & Blennow, K. (2003). Intrathecal inflammation precedes development of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 74, 1200-1205. (Pubitemid 37152241)
34. Taylor, V. H.; & Macqueen, G. M. (2010). The role of adipokines in understanding the associations between obesity and depression. Journal of Obesity,. doi: 10.1155/2010/748048.
35. Une, K.; Takei, Y. A.; Tomita, N.; Asamura, T.; Ohrui, T.; Furukawa, K.; et al. (2011). Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. European Journal of Neurology, 18(7), 1006-1009. doi: 10.1111/j.1468-1331.2010.03194.x.
36. van Himbergen, T. M.; Beiser, A. S.; Ai, M.; Seshadri, S.; Otokozawa, S.; Au, R.; et al. (2012). Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: Results from the Framingham Heart Study. Archives of Neurology, [Epub ahead of print]. doi: 10.1001/archneurol.2011.670.
37. Wolf, A. M.; Wolf, D.; Rumpold, H.; Enrich, B.; & Tilg, H. (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochemical and Biophysical Research Communications, 323(2), 630-635. doi: 10.1016/j.bbrc.2004.08.145. (Pubitemid 39221142)
38. Yokota, T.; Oritani, K.; Takahashi, I.; Ishikawa, J.; Matsuyama, A.; Ouchi, N.; et al. (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96(5), 1723-1732. (Pubitemid 30661055)
39. Zuliani, G.; Ranzini, M.; Guerra, G.; Rossi, L.; Munari, M. R.; Zurlo, A.; et al. (2007). Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. Journal of Psychiatric Research, 41, 686-693. doi: 10.1016/j.jpsychires.2006.02.008. (Pubitemid 46498101)